Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5265884
Max Phase: Preclinical
Molecular Formula: C46H76N4O10
Molecular Weight: 845.13
Associated Items:
ID: ALA5265884
Max Phase: Preclinical
Molecular Formula: C46H76N4O10
Molecular Weight: 845.13
Associated Items:
Canonical SMILES: C[C@@H]1CC[C@H]2[C@@H](C)C(CCC(=O)NCCCN3CCN(CCCNC(=O)CCC4O[C@H]5O[C@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)CC3)O[C@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4
Standard InChI: InChI=1S/C46H76N4O10/c1-29-9-11-35-31(3)37(53-41-45(35)33(29)17-19-43(5,55-41)57-59-45)13-15-39(51)47-21-7-23-49-25-27-50(28-26-49)24-8-22-48-40(52)16-14-38-32(4)36-12-10-30(2)34-18-20-44(6)56-42(54-38)46(34,36)60-58-44/h29-38,41-42H,7-28H2,1-6H3,(H,47,51)(H,48,52)/t29-,30-,31-,32-,33+,34+,35+,36+,37?,38?,41+,42+,43+,44+,45-,46-/m1/s1
Standard InChI Key: JVHGAAKZMCRLRS-OAZVRWERSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 845.13 | Molecular Weight (Monoisotopic): 844.5561 | AlogP: 5.68 | #Rotatable Bonds: 14 |
Polar Surface Area: 138.52 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: 7.97 | CX LogP: 5.41 | CX LogD: 4.73 |
Aromatic Rings: 0 | Heavy Atoms: 60 | QED Weighted: 0.16 | Np Likeness Score: 0.88 |
1. Fröhlich T, Çapcı Karagöz A, Reiter C, Tsogoeva SB.. (2016) Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents., 59 (16): [PMID:27010926] [10.1021/acs.jmedchem.5b01380] |
Source(1):